8-9141183-C-G
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The ENST00000310455.4(PPP1R3B):āc.469G>Cā(p.Glu157Gln) variant causes a missense change. The variant allele was found at a frequency of 0.0000489 in 1,614,210 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000039 ( 0 hom., cov: 32)
Exomes š: 0.000050 ( 1 hom. )
Consequence
PPP1R3B
ENST00000310455.4 missense
ENST00000310455.4 missense
Scores
6
12
Clinical Significance
Conservation
PhyloP100: 6.09
Genes affected
PPP1R3B (HGNC:14942): (protein phosphatase 1 regulatory subunit 3B) This gene encodes the catalytic subunit of the serine/theonine phosphatase, protein phosphatase-1. The encoded protein is expressed in liver and skeletal muscle tissue and may be involved in regulating glycogen synthesis in these tissues. This gene may be a involved in type 2 diabetes and maturity-onset diabetes of the young. Alternate splicing results in multiple transcript variants that encode the same protein.[provided by RefSeq, Jan 2011]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.2555698).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PPP1R3B | NM_024607.4 | c.469G>C | p.Glu157Gln | missense_variant | 2/2 | ENST00000310455.4 | NP_078883.2 | |
PPP1R3B | NM_001201329.2 | c.469G>C | p.Glu157Gln | missense_variant | 2/2 | NP_001188258.1 | ||
PPP1R3B | XM_006716253.4 | c.469G>C | p.Glu157Gln | missense_variant | 2/2 | XP_006716316.1 | ||
PPP1R3B | XM_047422235.1 | c.469G>C | p.Glu157Gln | missense_variant | 2/2 | XP_047278191.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PPP1R3B | ENST00000310455.4 | c.469G>C | p.Glu157Gln | missense_variant | 2/2 | 1 | NM_024607.4 | ENSP00000308318 | P1 | |
PPP1R3B | ENST00000519699.1 | c.469G>C | p.Glu157Gln | missense_variant | 2/2 | 2 | ENSP00000428642 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152202Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
6
AN:
152202
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000795 AC: 20AN: 251440Hom.: 0 AF XY: 0.000125 AC XY: 17AN XY: 135898
GnomAD3 exomes
AF:
AC:
20
AN:
251440
Hom.:
AF XY:
AC XY:
17
AN XY:
135898
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000499 AC: 73AN: 1461890Hom.: 1 Cov.: 35 AF XY: 0.0000743 AC XY: 54AN XY: 727246
GnomAD4 exome
AF:
AC:
73
AN:
1461890
Hom.:
Cov.:
35
AF XY:
AC XY:
54
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152320Hom.: 0 Cov.: 32 AF XY: 0.0000805 AC XY: 6AN XY: 74492
GnomAD4 genome
AF:
AC:
6
AN:
152320
Hom.:
Cov.:
32
AF XY:
AC XY:
6
AN XY:
74492
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
9
Asia WGS
AF:
AC:
1
AN:
3478
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 25, 2024 | The c.469G>C (p.E157Q) alteration is located in exon 2 (coding exon 1) of the PPP1R3B gene. This alteration results from a G to C substitution at nucleotide position 469, causing the glutamic acid (E) at amino acid position 157 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
M_CAP
Benign
D
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Benign
L;L
MutationTaster
Benign
D;D
PrimateAI
Uncertain
T
PROVEAN
Uncertain
N;N
REVEL
Benign
Sift
Benign
T;T
Sift4G
Benign
T;T
Polyphen
B;B
Vest4
MutPred
Gain of MoRF binding (P = 0.0198);Gain of MoRF binding (P = 0.0198);
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at